| scholarly article | Q13442814 |
| P2093 | author name string | Unzueta A | |
| Rakela J | |||
| P2860 | cites work | Hepatitis E, a vaccine-preventable cause of maternal deaths | Q26852254 |
| A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries | Q33545709 | ||
| Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif | Q34120153 | ||
| Molecular virology of hepatitis E virus | Q34166393 | ||
| Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance | Q35067078 | ||
| From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety | Q35078635 | ||
| Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain | Q35216125 | ||
| Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France | Q35817883 | ||
| Hepatitis E virus antibodies in blood donors, France | Q35849075 | ||
| Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients | Q36246311 | ||
| Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. | Q36584546 | ||
| World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. | Q36825509 | ||
| Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury | Q36845686 | ||
| The role of hepatitis E virus testing in drug-induced liver injury. | Q36938489 | ||
| Chronic hepatitis E virus infection in liver transplant recipients | Q37126185 | ||
| Hepatitis E: an emerging infection in developed countries. | Q37320904 | ||
| Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994 | Q37389167 | ||
| Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review | Q37608678 | ||
| The two faces of hepatitis E virus | Q37767237 | ||
| Hepatitis E virus infection | Q38090922 | ||
| Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. | Q42632838 | ||
| Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection | Q42938081 | ||
| Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan | Q43218736 | ||
| Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands | Q43222721 | ||
| Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and Primer-Probe Energy Transfer | Q43223121 | ||
| Chronic hepatitis E infection in children with liver transplantation | Q43230495 | ||
| Chronic hepatitis e in heart transplant recipients | Q43443385 | ||
| Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin | Q43778502 | ||
| Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience | Q43974173 | ||
| Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays | Q44031570 | ||
| Chronic hepatitis E infection in lung transplant recipients | Q44180185 | ||
| Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants | Q44790182 | ||
| Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients | Q45007033 | ||
| Hepatitis E masquerading as drug-induced liver injury | Q45141478 | ||
| How should hepatitis E virus infection be defined in organ-transplant recipients? | Q45351318 | ||
| Hepatitis E virus infection in a liver transplant recipient in the United States: a case report | Q45352167 | ||
| Suppression of interferon-α signaling by hepatitis E virus | Q45360949 | ||
| Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection | Q45362400 | ||
| Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation | Q45367134 | ||
| Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France | Q45373867 | ||
| Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease | Q45393741 | ||
| Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. | Q45394398 | ||
| Hepatitis E virus and chronic hepatitis in organ-transplant recipients | Q45397012 | ||
| Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death | Q45409801 | ||
| A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus | Q45424338 | ||
| Chronic hepatitis E with cirrhosis in a kidney-transplant recipient | Q46743789 | ||
| Nasal CPAP for very preterm infants | Q47658079 | ||
| Treatment of severe acute hepatitis E by ribavirin. | Q50555678 | ||
| Brief communication: case reports of ribavirin treatment for chronic hepatitis E. | Q50559518 | ||
| Subacute hepatic failure due to hepatitis E. | Q51728527 | ||
| Hepatitis E | Q55934378 | ||
| Hepatitis E | Q56656388 | ||
| Hepatitis E | Q56769659 | ||
| Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient | Q58097375 | ||
| Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? | Q58865446 | ||
| P433 | issue | 1 | |
| P921 | main subject | hepatitis E | Q326643 |
| P304 | page(s) | 15-24 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | Hepatitis E infection in liver transplant recipients | |
| P478 | volume | 20 |
| Q52649373 | Absence of chronic hepatitis E virus infection in liver transplant recipients: Report from a hyperendemic region. |
| Q86886381 | Autoimmune hepatitis |
| Q56915346 | Hepatitis E Virus |
| Q47156053 | Hepatitis E: A Literature Review |
| Q59335763 | Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease |
| Q50275751 | Treatment with ribavirin for chronic hepatitis E following living donor liver transplantation: A case report |
| Q97067881 | Viral Hepatitis Other than A, B, and C: Evaluation and Management |
Search more.